Login
$UNCY
$3.70 +$0.00 (0.0%) After hours

$UNCY SEC Filings

Filed On Filing
16 Nov 2026 8-K: Results of Operations and Financial Condition

Date of Report (Date of earliest event reported): November 16, 2026

16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 10-Q
29 Oct 2026 Form 4: Manning Meredith, Director

Granted 3,350 Restricted Stock Units · Granted 27,000 Stock Options

01 Oct 2026 Form 3: Manning Meredith, Director

No securities owned

29 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

Resubmission of NDA includes Chemistry, Manufacturing, and Controls (CMC) data from a new drug product manufacturing vendor

28 Sep 2026 8-K: Other Events

On September 3, 2026, a securities class action lawsuit was filed in United States District Court for the Northern District of California against Unicycive Therapeutics, Inc. (the “Company”) and certain of its officers. This action alleg...

14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 8-K: Results of Operations and Financial Condition

- Company expects to resubmit New Drug Application (NDA) for oxylanthanum carbonate (OLC) assuming completion of successful inspection of third-party manufacturing vendor

12 Aug 2026 QUARTERLY REPORT
30 Jul 2026 SCHEDULE 13G
28 Jul 2026 Form 4/A: Kenkare-Mitra Sara, Director

Granted 47,941 Restricted Stock Units

28 Jul 2026 Form 4/A: Laumas Sandeep, Director

Granted 47,941 Restricted Stock Units

08 Jul 2026 SCHEDULE 13G/A
02 Jul 2026 8-K: Other Events

The Company had an ending cash balance of approximately $61.4 million as of June 30, 2026.

01 Jul 2026 144
22 Jun 2026 CURRENT REPORT
22 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 19, 2025, Unicycive Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). A total of 14,964,159 shares of common stock, constituting a quorum, were represented in person or by valid pr...

15 Jun 2026 EFFECT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support